NewSouth Innovations

NewSouth Innovations (NSi) is the commercialization company of the University of New South Wales (UNSW Sydney), serving as the primary vehicle for translating academic research into commercial products and services. The organization manages a vast portfolio of intellectual property across diverse sectors, with a particular emphasis on life sciences, biotechnology, and medical technology. NSi provides comprehensive support for patenting, licensing, and the formation of spin-out companies, bridging the gap between laboratory discovery and market application. By partnering with industry leaders and investors, NSi facilitates the development of innovative therapies and devices, including notable advancements in bionic vision and oncology. Its operations are central to UNSW's mission of achieving global impact through research excellence and industry engagement.